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Objectives: To evaluate (1) whether or not the addition of computer-assisted diagnosis (CAD) 
to 64-slice multidetector computed tomography (CT) can be used as a screening tool for   
detection of pulmonary nodules in routine CT chest examinations and (2) whether or not to 
advocate the incorporation of CAD as a screening tool into our daily practice.
Materials and methods: A retrospective cross-sectional analysis of 109 consecutive patients 
who had all undergone routine contrast-enhanced CT chest examinations for indications other 
than lung cancer at the Radiology Department of Aga Khan University Hospital, Karachi, between 
November 2010 and January 2011. All examinations were evaluated in terms of the detection 
of pulmonary nodules by a consultant radiologist and CAD (ImageChecker CT Algorithm R2 
Technology) software. The ability of CAD software to detect pulmonary nodules was evaluated 
against the reference standard. In addition, a chest radiologist also calculated the number of 
pulmonary nodules. The sensitivity and specificity of the CAD software were   calculated against 
the reference standard by using a 2 × 2 table. The Mann−Whitney U test was applied to compare 
the performances of CAD and the radiologist.
Results: CAD detected 610 pulmonary nodules while the radiologist detected only 113. The 
reference standard declared 198 pulmonary nodules to be true nodules. CAD detected 95% 
of all true nodules (189/198), whereas the radiologist detected only 57% (113/198). In the 
detection of true pulmonary nodules, CAD had 98% sensitivity compared with the radiolo-
gist who had 57% sensitivity; the statistical difference between their performances had a P 
value ,0.001.
Conclusion: Considering the high sensitivity of CAD to detect nearly all true pulmonary 
nodules, we advocate its application as a screening tool in all CT chest examinations for the 
early detection of pulmonary nodules and lung carcinoma.
Keywords: CT chest examinations, pulmonary nodules, lung carcinoma, computer-assisted 
diagnosis
Introduction
Lung carcinomas are one of leading causes of death worldwide. It has been estimated 
that over 1 million people die every year from secondary lung cancer.1 The mean 
5-year survival rate of lung cancer is 15% but with early detection and treatment the 
overall survival rate can be improved from 15% up to 70%.2–4 Unfortunately, only 
15% of lung cancers are detected at this early stage and that figure has remained 
unchanged over the last three decades.5 Missed lung cancer is a serious challenge for 
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both radiologists and pulmonologists. Chest X-rays are the 
initial method of investigation but computed tomography is 
more sensitive than projectional radiography in the detection 
of small pulmonary nodules.6
With the advent of multidetector computed tomography 
(MDCT), especially 64-slice, it has become possible to 
acquire several thin slices in a single breath hold and allow 
image reconstruction in axial, coronal, and sagittal planes7 
without affecting spatial resolution. This not only produces 
a large amount of imaging data but also increases the burden 
on already overworked radiologists.
Recently developed computer-assisted diagnosis (CAD) 
has gained worldwide acceptance, not only because of its 
ability to handle increasing amounts of data but also due to 
its detection of pulmonary nodules and filling defects for 
pulmonary embolism, and its capacity to estimate interstitial 
pulmonary diseases.8
Since no lung cancer screening programs are   available in 
our part of the world, the use of CAD may help in   diagnosing 
lung cancer at an earlier stage. No study has been done in our 
region to look at the applicability of CAD for use as a screening 
tool in the detection of pulmonary nodules.   Therefore, the 
purpose of our study was to evaluate whether the addition of 
CAD of pulmonary nodules in routine 64-slice MDCT of the 
lung has any role in patient management and, on the basis of 
its results, whether or not to advocate for the incorporation of 
CAD as a screening tool into our daily practice.
Materials and methods
One hundred and nineteen consecutive patients of both 
  genders coming to the Radiology Department of Aga 
Khan University Hospital, Karachi for the routine chest 
CT scan with all indications between November 2010 and 
  January 2011 were retrospectively selected. Ten patients 
were excluded from the study because of lung collapse 
involving more than one lobe, pneumonectomy, significant 
lung fibrosis, or breathing artifacts interfering with the 
interpretation of scan. Finally, 109 exams were included in 
the study. All patients underwent contrast-enhanced chest 
CT scans using a Toshiba Aquilion 64 slice CT scanner, 
following routine departmental protocols which include 
120 kVp, 200 mAs, pitch standard, 0.5 second gantry rota-
tion time. One hundred milliliters of intravenous contrast 
iohexol, 350 mg/mL iodine (Omnipaque, GE Healthcare, 
Waukesha, WI) were given through computer-controlled 
mechanical power injector at a rate of 3 mL/second. There 
was a delay of 60 seconds before initiation of the scan. 
Volume data were acquired from a section thickness of 
0.5 × 64 mm that was subsequently reconstructed to 1 mm 
and 5 mm axial, coronal, and sagittal sections. A series 
of 1 mm axial images were sent to the CAD software 
based on automatic detection of pulmonary nodules and 
all images were sent to the PACS (picture archiving and 
communication system) workstation for identification of 
  pulmonary nodules by a consultant radiologist with more 
than 5 years’ experience in chest CT reporting. The pul-
monary nodules calculated by the radiologist (RAD) were 
labeled as the RAD group and the pulmonary nodules 
calculated by computer-based software were labeled as the 
CAD group. Our CAD software is ImageChecker CT server 
algorithm (R2 Technology, Bedford, MA; see Figure 1) 
which is designed to detect lung nodules by identifying the 
solid parenchymal focal densities in the lung tissue 4 mm 
in diameter or larger and pleural-based nodules 4 mm or 
larger, provided they project significantly into the lung and 
are approximately spherical in shape, have boundaries that 
are smooth, lobulated, or speculated, and are surrounded 
by lung parenchyma.9,10
Pulmonary nodules (,15 mm) identified by CAD 
software were recorded on Performa, labeled as the CAD 
group. Two senior radiologists with 10 years’ experience in 
CT chest reporting in conjunction with a final-year radiology 
resident, all of whom were trained to work on CAD software, 
reviewed all CT examinations for the determination of 
true nodules and their findings were taken as the reference 
standard. The nodule were considered to be: (1) true positive 
when an opacity in the lung was declared to be a nodule by 
CAD/RAD and also confirmed by the reference standard; 
false positive when an opacity in the lung was declared to 
be a nodule by CAD/RAD but was not confirmed by the 
reference standard; (3) false negative when an opacity in the 
lung was not declared to be a nodule by CAD/RAD but was 
declared to be a nodule by the reference standard; and (4) 
true negative when an opacity in the lung was declared not 
to be a nodule by both CAD/RAD and also by the reference 
standard.
Statistical analysis was performed using SPSS   Windows 
package (v 16; SPSS Inc, Chicago, IL). Descriptive 
analysis was conducted, ie, frequencies and percentages for 
categorical variables such as sex, presence and absence of 
pulmonary nodules, and mean and standard deviation for 
continuous variables such as age. Considering the distribution 
of data, the Mann−Whitney U test was used to compare the 
medians of CAD and RAD against the reference standard. 
The sensitivity of the CAD and RAD groups was calculated 
against the reference standard.
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Results
There were 58% males with a mean age of 36.7 years 
(range 19−63 years) and 42% females with a mean age 
of 44.4 years (range 22−84 years). The overall mean age 
was 39.9 years (range 19−84). Five percent of the females 
and 80% of the males had a positive history of smoking. 
CAD detected 610 nodules in 87 patients (seven nodules 
per patient), excluding 22 examinations as negative for the 
presence of nodules, whereas the RAD detected 113 nodules 
in 37 patients, with an average of three nodules per patient, 
and the rest of the 72 examinations were declared negative for 
the presence of pulmonary nodules. The reference standard 
calculated a total of 198 nodules in 62 patients (average 3.2) 
and the remaining 47 patients’ scans were declared negative. 
The maximum size of the nodules was 15 mm with an average 
size of 5.8 mm (range 4−15 mm). Of all CAD-detected 
nodules 31% (192/610) were true nodules and 68% (418/610) 
were false positive, contributing to the significant overcall 
rate. CAD picked up 95% (189/198) of all true nodules; 
however, about 1.4% (9/198) of true nodules were missed. 
In the detection of pulmonary nodules, CAD has a very high 
sensitivity of 98%. On the other hand, all nodules detected 
by the RAD were true nodules but he missed 85 true nodules 
(43%, 85/198), contributing to the RAD false-negative rate. 
There were no false-positive nodules for RAD. In the detec-
tion of pulmonary nodules, the RAD has a poor sensitivity 
of 57% (see Table 1). When we applied the Mann−Whitney 
U test to the findings of both groups (CAD and RAD), we 
found a statistically significant difference (P , 0.001).
Discussion
Missed lung cancers remain a challenge for both radiologists 
and clinicians. The pulmonary nodules less than 15 mm in 
diameter are the potential nodules which are missed and 
have been reported as having a high probability of being 
stage 1 lung cancer.4 Unfortunately, the majority of patients 
are unable to seek medical attention because of lack of 
awareness, and no screening programs are available in 
underdeveloped countries. In one of the screening   studies 
conducted by Kaneko et al, 32% of lung cancers were 
Table 1 Detection performance of true pulmonary nodules
True nodules (198) CAD RAD Sensitivity P value
True nodules detected 189/198 113/198 98% ,0.001
True nodules missed 90/198 85/198 57% ,0.001
Abbreviations: CAD, computer-aided diagnosis; RAD, radiologist.
Figure 1 CAD software. In the left-hand corner are various operational tools while in the center, the main window shows the lung under study. In the right-hand corner 
multiplanar views of the lung can be seen.
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initially missed but subsequently diagnosed on follow-up 
imaging.11
In a study conducted by Swenson et al, radiologists 
missed pulmonary nodules in about 26% of patients.12 In our 
study, the radiologist missed nodules in about 35% (25/72) of 
patients and the RAD sensitivity in picking up nodules was 
only 57%. This may be due to the large number of images 
produced by MDCT which not only increases the workload 
of the   radiologist but can also lead to oversight errors and 
paradoxical cases.13 This requires double reading, which can 
effectively be provided by CAD using artificial intelligence 
and vision.14
Wide variation exists in the literature regarding the 
  efficiency of CAD but none of the studies evaluated CAD 
as a screening modality; most have applied the CAD 
software in screening CT lung examinations which are not 
being   routinely done in our part of world. We assessed the 
  applicability of commercially available CAD as a screening 
tool in routine CT chest examinations with a normal radiation 
dose which were performed for indications other than the 
lung cancer screening. The main indications were dyspnea, 
trauma, infections, chronic obstructive pulmonary disease, 
interstitial lung diseases, and metastatic workup.
In our study, CAD performed much better than the RAD 
and picked up 95% (189/198) of true nodules; however, about 
1.4% (9/198) of the true nodules were missed. In a series con-
ducted by Yuan et al, nearly one-quarter of the nodules were not 
picked up by CAD15 but in our study CAD missed very few.
CAD has a significant overcall rate, contributing to its 
number of false positives – the problem which has been 
identified in almost all studies conducted so far on this 
particular topic of the computer-aided detection of pulmo-
nary nodules. In our study, CAD falsely marked nodules in 
34% of the patients, which were declared negative by the 
reference standard. The reasons for the CAD false positives 
in our study were end-on vessels 44% (184/418), round/oval 
areas of atelectasis 27% (113/418), scars 13% (56/418), and 
osteophytes projecting into the lung surface 16% (65/418).
On the other hand, all nodules detected by RAD were 
true nodules but they missed a significant number of true 
nodules (85/198). The RAD false-negative rate can pose a 
significant risk of morbidity and mortality in terms of missed 
lung cancer and is unacceptable in this era of sophisticated 
technology. This significant false-negative rate may be due 
not only to overwork but also to oversight errors caused by 
distraction, hurry due to time limits, and the subtlety of the 
lesions. CAD is immune from these errors and picks up the 
nodules missed by radiologists.
Regarding the sensitivity of CAD in the detection of 
  pulmonary nodules, there is wide variation in the literature. In 
a study conducted by Yuan et al,15 CAD has 73% sensitivity 
and in a study by Goo et al,16 65% sensitivity. In our study, 
the sensitivity of CAD in picking up pulmonary nodules was 
98% which is the highest to date in the reported literature 
in patients with normal-dose CT chest examinations. The 
sensitivity of CAD was 94% in a study by Fraioli et al17 but 
they used low-dose protocols with a small number (20) of 
patients. The CAD false-positive is different from that of the 
radiologist and can easily be eliminated with the expertise 
of the radiologist and is unlikely to increase the number of 
unnecessary biopsies. It may, however, increase patient costs 
in terms of follow-up because any suspicious nodule has to 
be in surveillance: a nodule that remains stable for up to a 
period of 2 years is considered to be benign.18 The false-
negative rate of CAD in our study is significantly less than 
the false-negative rate published in the literature, which may 
be due to differences in CAD software, difference in image 
thickness, and variability in reference standards. There is 
strong evidence in the literature that CAD picks up not only 
additional nodules but also those nodules which were initially 
missed by radiologists and diagnosed later on in follow-up 
studies.8,19,20 Therefore, considering the high sensitivity and 
ability of CAD to detect nearly all nodules, it may be applied 
to all CT chest examinations for the purpose of screening 
pulmonary nodules. It is cost effective and safe, but also 
noninvasive and requires minimal expertise to operate. The 
results can be reproduced and will not entail an additional 
radiation dose to the patient because CAD will be applied 
to already-performed CT chest examinations.
There were several limitations to our study. It was 
a retrospective study of a sample with a wide variety of 
indications. In addition, partly necrotic nodules were not 
evaluated in this study. The higher false-negative rate of the 
RAD in comparison to CAD can partially be attributed to 
time constraints, slice thickness, and workload, as calculating 
each and every nodule is time consuming. Studies have 
shown that thin-slice images detect more nodules than thicker 
sections;20–22 however, the radiologist also had additional 
coronal and sagittal sets of images which are very helpful 
in assessing the suspicious lesion in all three dimensions. 
Nevertheless, a study conducted by Aberle et al22 has shown 
significantly reduced lung-cancer mortality with low-dose 
CT screening. In our study, no additional radiation dose was 
given to the patient because we added CAD to the already-
performed chest CT scan for other clinical indications such 
as trauma, infection, malignancy, and metastatic workup. 
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The purpose of our study was to evaluate whether we can 
use CAD as a screening tool by comparing its performance 
against the reference standard and the reporting radiologist. 
The majority of our patients had a positive history of smoking 
and we do not know what percentage of detected nodules 
will become neoplastic and what percentage are benign. For 
these patients, follow-up is crucial to keep a close eye on the 
character of the nodule so that if any become malignant, they 
can be dealt with in a prompt and timely manner.
The results of our study have shown the additional 
  benefits of CAD in the detection of pulmonary nodules so 
we advocate the additional application of CAD to every chest 
CT examination as a screening tool for timely identification 
of pulmonary nodules.
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